Pharma Stock Roundup: LLY, NVO, BAYRY Q2 Earnings, MRK’s New Deal & Other Updates
ZacksEli Lilly (LLY), Novo Nordisk (NVO) and Bayer (BAYRY) announce second-quarter results. Merck (MRK) expands existing co-development deal with partner Daiichi Sankyo.